Avasimibe

DB06442ExperimentalSmall molecule

Investigated for use/treatment in peripheral vascular disease.

Mechanism: Pharmacologically active on Liver carboxylesterase 1
Curator reviewed
Primary indication: Investigated for use/treatment in peripheral vascular disease.Curator reviewed
Formula / weight: C₂₉H₄₃NO₄S · 501.73 g/mol (avg)
Code names: CI-1011

Resolves to

Compound

Structure

InChIKeyPTQXTEKSNBVPQJ-UHFFFAOYSA-NSMILESCC(C)C1=CC(C(C)C)=C(CC(=O)NS(=O)(=O)OC2=C(C=CC=C2C(C)C)C(C)C)C(=C1)C(C)C

Targets

What you can answer from here — as of August 30, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

582Drug interactionsStructured to mechanism, not free text

8+ReferencesStructured and connected to the statements they support

Which drugs share a target with Avasimibe, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.